UK’s new Health Research Authority gets underway
This article was originally published in Clinica
The UK government's plan to rationalise and improve the country's regulation of health research got underway on 1 December, with the creation of the Health Research Authority (HRA).
You may also be interested in...
Citing challenges posed by the COVID-19 pandemic, EU regulators have extended the deadline for companies to finish nitrosamine-related risk evaluations.
The Australian health care products regulator is inviting feedback on proposed measures to clarify the boundary for software-based products that are captured under the regulatory framework for medical devices.
A draft EU guideline explains how companies can ensure that data from ongoing clinical trials remains relevant for regulatory decision-making despite problems posed by the COVID-19 pandemic.